MANHASSET, NY – An investigational drug demonstrated a reduction in depressive symptoms in women suffering from severe postpartum depression (PDD), a potentially significant development for the one in seven women in the United States who are afflicted, according to clinical trial data published in the prestigious journal The Lancet. The publication of findings from this multi-site,…